Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole + tamoxifen + estradiol ± vitamin E for ovulation induction in PCOS
IRCT20150407021653N20Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and female infertility comparing Letrozole + tamoxifen + estradiol + vitamin E with Letrozole + tamoxifen + estradiol (2 arms). Started Jan 2024; status: completed.
02
Drugs
letrozoletamoxifenestradiolvitamin e
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20150407021653N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150407021653N20.